11 - 16 of 16 Results
Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).
Compliance in a part, work holding, or base plate is beneficial for certain processes, but detrimental for machining and material removal.
In additive manufacturing large stresses are induced in the build plate and part interface. A result of theses stresses are deformations in the build plate and final component.
There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).
The invention provides on-line analysis of droplets for mass spectrometry.